Showing results (41-50 of 218) with videos related to

Sort By:
Pageof 22
Neuroscience|November 5, 2017
Graph Theoretical Framework of Brain Networks in Multiple Sclerosis: A Review of ConceptsVinzenz Fleischer, Angela Radetz, Dumitru Ciolac, et al.
Scientific Reports|December 29, 2019
Multimodal alterations of directed connectivity profiles in patients with attention-deficit/hyperactivity disordersMuthuraman Muthuraman, Vera Moliadze, Lena Boecher, et al.
CNS Drugs|October 2, 2023
Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based StudyYaroslav Winter, Katharina Sandner, Thomas Vieth, et al.
Analytical Chemistry|October 27, 2025
prm-PASEF-Based Quantification and Isomeric Model for Extended Coverage of Human Plasma Lipidome in Parkinson's DiseaseDhanwin Baker, Gabriel Gonzalez Escamilla, Daniel Janitschke, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 12, 2025
Neuroimaging in advanced Parkinson's disease: insights into pathophysiology, biomarkers, and personalized therapiesNils Schröter, Sergiu Groppa, Michel Rijntjes, et al.
Epilepsia|February 25, 2012
White matter microstructural changes of thalamocortical networks in photosensitivity and idiopathic generalized epilepsySergiu Groppa, Friederike Moeller, Hartwig Siebner, et al.
Frontiers in Neurology|September 14, 2018
Deep Brain Stimulation and L-DOPA Therapy: Concepts of Action and Clinical Applications in Parkinson's DiseaseMuthuraman Muthuraman, Nabin Koirala, Dumitru Ciolac, et al.
Biomedical Optics Express|December 1, 2017
Dynamics of the human brain network revealed by time-frequency effective connectivity in fNIRSGrégoire Vergotte, Kjerstin Torre, Venkata Chaitanya Chirumamilla, et al.
Metabolites|June 2, 2021
Identification of Potential Distinguishing Markers for the Use of Cannabis-Based Medicines or Street Cannabis in Serum SamplesAnne Scheunemann, Katrin Elsner, Tanja Germerott, et al.
CNS Drugs|September 30, 2022
Eslicarbazepine Acetate as Adjunctive Therapy for Primary Generalized Tonic-Clonic Seizures in Adults: A Prospective Observational StudyYaroslav Winter, Katharina Sandner, Thomas Ludger Vieth, et al.
Pageof 22